0031 INHERITED VARIATION IN CIRCADIAN RHYTHM GENES AND RISKS OF PROSTATE CANCER AND THREE OTHER CANCER SITES IN COMBINED CANCER CONSORTIA

File Description SizeFormat 
Inherited variation in circadian rhythm genes.pdfAccepted version404.91 kBAdobe PDFDownload
Title: 0031 INHERITED VARIATION IN CIRCADIAN RHYTHM GENES AND RISKS OF PROSTATE CANCER AND THREE OTHER CANCER SITES IN COMBINED CANCER CONSORTIA
Author(s): Gu, F
Zhang, H
Hyland, PL
Berndt, S
Gapstur, SM
Wheeler, W
Shi, J
Yu, K
Teresa Landi, M
Caporaso, NE
Item Type: Journal Article
Abstract: Introduction: Circadian disruption has been linked to carcinogenesis in animal models and to breast cancer in humans. However, the evidence for other types of cancer is inconclusive. Variations in genes involved in circadian rhythm provide a tool to investigate such associations. Methods: We examined associations of genetic variation in nine core circadian rhythm genes and six melatonin pathway genes with risk of colorectal, lung, ovarian and prostate cancers using genome-wide association studies (GWAS) from GAME-ON. The major results for prostate cancer were replicated in PLCO, and for colorectal cancer in GECCO. The total number of cancer cases and controls was 15,838/18,159 for colorectal, 14,818/14,227 for prostate, 12,537/17,285 for lung and 4,369/9,123 for ovary. For each cancer site, we used the SNP summary statistics for the candidate gene regions imputed to 1000 Genomes. Gene-level and pathway-level analyses were conducted using the summary-based Adaptive Rank Truncated Product method (sARTP). Results: Aggregate genetic variation in circadian rhythm and melatonin pathways were significantly associated with the risk of prostate cancer in data combining GAME-ON and PLCO, after Bonferroni correction (Ppathway<0.00625). The two most significant genes were NPAS2 (Pgene=0.0062) and AANAT (Pgene=0.00078); the latter being significant after Bonferroni correction. For colorectal cancer, we observed a suggestive association with the circadian rhythm pathway in GAME-ON (Ppathway=0.021), that was not confirmed in GECCO (Ppathway=0.76) or the combined data (Ppathway=0.17). No other association was observed for the other cancer sites. Conclusion: These findings support a potential role for circadian rhythm and melatonin pathways in prostate carcinogenesis. Further functional studies are needed to better understand the underlying biologic mechanisms.
Publication Date: 28-Apr-2017
Date of Acceptance: 1-Apr-2017
URI: http://hdl.handle.net/10044/1/48680
DOI: https://dx.doi.org/10.1093/sleepj/zsx050.030
ISSN: 0161-8105
Publisher: Oxford University Press
Start Page: A12
End Page: A12
Journal / Book Title: Sleep
Volume: 40
Issue: suppl_1
Copyright Statement: © 2017 Sleep Research Society. Published by Oxford University Press [on behalf of the Sleep Research Society]. All rights reserved. For permissions, please email: journals.permissions@oup.com. This is a pre-copy-editing, author-produced version of an article accepted for publication in SLEEP following peer review. The definitive publisher-authenticated version F Gu, H Zhang, PL Hyland, S Berndt, SM Gapstur, W Wheeler, J Shi, K Yu, M Teresa Landi, NE Caporaso; 0031 INHERITED VARIATION IN CIRCADIAN RHYTHM GENES AND RISKS OF PROSTATE CANCER AND THREE OTHER CANCER SITES IN COMBINED CANCER CONSORTIA. Sleep 2017; 40 (suppl_1): A12. doi: 10.1093/sleepj/zsx050.030 is available online at: https://dx.doi.org/10.1093/sleepj/zsx050.030
Sponsor/Funder: Imperial College Trust
Funder's Grant Number: P47328
Keywords: Neurology & Neurosurgery
06 Biological Sciences
11 Medical And Health Sciences
17 Psychology And Cognitive Sciences
Publication Status: Published
Appears in Collections:Faculty of Medicine
Epidemiology, Public Health and Primary Care



Items in Spiral are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons